When compared with sham-operated group (reference as 1), protein expression of Bcl-2 (Fig. 4C) and Bcl-xL (Fig. 4D) was markedly reduced by stroke at both 6 (F[5,42]=47.5, p<0.001; F[5,42]=16.2, p<0.05) and 24 h (F[5,42]=60.0, p<0.001; F[5,42]=8.3, p<0.05). The gene discussed is BCL2; the disease is stroke disorder.